73
Views
7
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Manidipine treatment in patients with albuminuria not sufficiently reduced with renin–angiotensin system blockers

, , , , &
Pages 751-757 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Antonio Coca, Pilar Mazón, Pedro Aranda, Josep Redón, Juan Antonio Divisón, Javier Martínez, Carlos Calvo, Josep María Galcerán, Vivencio Barrios & Alexandre Roca-Cusachs i Coll. (2013) Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Review of Cardiovascular Therapy 11:1, pages 91-105.
Read now
Carlos Escobar, Rocio Echarri & Vivencio Barrios. (2012) Emerging drug combinations to optimize renovascular protection and blood pressure goals. International Journal of Nephrology and Renovascular Disease 5, pages 69-80.
Read now

Articles from other publishers (5)

Margarita Saiz-Satjes, Francisco Javier Martinez-Martin & Alex Roca-Cusachs. (2017) Factors associated with the reduction of albumin excretion in diabetic hypertensive patients: differential effect of manidipine versus amlodipine. Future Cardiology 13:2, pages 143-151.
Crossref
Margarita Saiz Satjes & Francisco J Martinez-Martin. (2016) Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine. Future Cardiology 12:4, pages 435-447.
Crossref
Anastasia G Ptinopoulou, Maria I Pikilidou & Anastasios N Lasaridis. (2012) The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review. Hypertension Research 36:2, pages 91-101.
Crossref
Christian Ott, Markus P. Schneider, Ulrike Raff, Martin Ritt, Kristina Striepe, Marco Alberici & Roland E. Schmieder. (2013) Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension . British Journal of Clinical Pharmacology 75:1, pages 129-135.
Crossref
Ramón Cristófol AlluéFrancesc Manzanares Brotons. (2011) Efficacy and safety of manidipine in patients with hypertension aged 70 years or older. Aging Health 7:4, pages 521-528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.